• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

接受卟吩姆钠治疗的患者发生皮肤光毒性反应。

Cutaneous phototoxic occurrences in patients receiving Photofrin.

作者信息

Dougherty T J, Cooper M T, Mang T S

机构信息

Photodynamic Therapy Center, Roswell Park Cancer Institute, Buffalo, NY 14263.

出版信息

Lasers Surg Med. 1990;10(5):485-8. doi: 10.1002/lsm.1900100514.

DOI:10.1002/lsm.1900100514
PMID:2146455
Abstract

Incidence of cutaneous phototoxic reactions induced by intravenous injection of Photofrin polyporphyrin was assessed in a series of 180 patients (266 injections) undergoing photodynamic therapy (PDT) at Roswell Park Cancer Institute during the period 1986-1989. In addition to the usual verbal questions regarding phototoxic reactions solicited at follow-up, forty-two patients in this group also responded to a written questionnaire designed to solicit answers to specific questions. Photofrin doses ranged from 0.5 to 2.0 mg/kg. Overall, 20-40% of patients reported some type of phototoxic response.

摘要

1986年至1989年期间,在罗斯威尔公园癌症研究所对180例接受光动力疗法(PDT)的患者(共进行了266次注射)进行了评估,以确定静脉注射卟吩姆钠多卟啉引发皮肤光毒性反应的发生率。除了在随访时询问有关光毒性反应的常见口头问题外,该组中的42名患者还对一份旨在征求特定问题答案的书面问卷做出了回应。卟吩姆钠的剂量范围为0.5至2.0mg/kg。总体而言,20%至40%的患者报告了某种类型的光毒性反应。

相似文献

1
Cutaneous phototoxic occurrences in patients receiving Photofrin.接受卟吩姆钠治疗的患者发生皮肤光毒性反应。
Lasers Surg Med. 1990;10(5):485-8. doi: 10.1002/lsm.1900100514.
2
Prospective study of cutaneous phototoxicity after systemic hematoporphyrin derivative.全身应用血卟啉衍生物后皮肤光毒性的前瞻性研究。
Lasers Surg Med. 1988;8(3):294-300. doi: 10.1002/lsm.1900080312.
3
Skin photosensitivity: duration and intensity following intravenous hematoporphyrin derivates, HpD and DHE.皮肤光敏性:静脉注射血卟啉衍生物(HpD)和二氢卟吩(DHE)后的持续时间和强度
Photochem Photobiol. 1987 Nov;46(5):925-8. doi: 10.1111/j.1751-1097.1987.tb04870.x.
4
Long-term side effects after intramuscular injection of hematoporphyrin derivative.肌肉注射血卟啉衍生物后的长期副作用。
Photodermatol. 1986 Jun;3(3):197-9.
5
Induction of drug photosensitization in man after parenteral exposure to hematoporphyrin.
Arch Dermatol. 1977 Oct;113(10):1392-7.
6
A preliminary pharmacokinetic study of intravenous Photofrin in patients.静脉注射血卟啉单甲醚在患者中的初步药代动力学研究。
J Clin Laser Med Surg. 1996 Oct;14(5):311-4. doi: 10.1089/clm.1996.14.311.
7
[Photosensitization after intramuscular injections of hematoporphyrin. 3 cases].[肌肉注射血卟啉后的光敏反应。3例]
Ann Dermatol Venereol. 1987;114(4):543-9.
8
Phototoxicity of the chemotherapeutic agents hematoporphyrin D, meso-tetra(p-sulfophenyl)porphine and zinc-tetra(p-sulfophenyl)porphine.
Res Commun Chem Pathol Pharmacol. 1980 Nov;30(2):317-27.
9
[Recent developments in anticancer photochemotherapy].
Pathol Biol (Paris). 1991 Jan;39(1):54-8.
10
[Photosensitization complications after intramuscular injection of hematoporphyrin. Apropos of 23 cases].[肌肉注射血卟啉后的光敏并发症。附23例报告]
Ann Dermatol Venereol. 1981;108(1):95-101.

引用本文的文献

1
Recent development of nanomaterials-based PDT to improve immunogenic cell death.基于纳米材料的 PDT 最近的发展以改善免疫原性细胞死亡。
Photochem Photobiol Sci. 2024 Oct;23(10):1983-1998. doi: 10.1007/s43630-024-00638-y. Epub 2024 Sep 25.
2
Sequential dual-locking strategy using photoactivated Pt(IV)-based metallo-nano prodrug for enhanced chemotherapy and photodynamic efficacy by triggering ferroptosis and macrophage polarization.使用光活化的基于铂(IV)的金属纳米前药的顺序双锁定策略,通过引发铁死亡和巨噬细胞极化来增强化疗和光动力疗效。
Acta Pharm Sin B. 2024 Jul;14(7):3251-3265. doi: 10.1016/j.apsb.2024.02.024. Epub 2024 Mar 4.
3
The Essence of Lipoproteins in Cardiovascular Health and Diseases Treated by Photodynamic Therapy.
光动力疗法治疗心血管疾病中脂蛋白的本质
Biomedicines. 2024 Apr 26;12(5):961. doi: 10.3390/biomedicines12050961.
4
Photodynamic Therapy and Cardiovascular Diseases.光动力疗法与心血管疾病
Int J Mol Sci. 2024 Mar 4;25(5):2974. doi: 10.3390/ijms25052974.
5
A Bioorthogonal Antidote Against the Photosensitivity after Photodynamic Therapy.一种光动力治疗后光敏感性的生物正交解毒剂。
Adv Sci (Weinh). 2024 Mar;11(11):e2306207. doi: 10.1002/advs.202306207. Epub 2023 Dec 31.
6
The use of nanomaterials in advancing photodynamic therapy (PDT) for deep-seated tumors and synergy with radiotherapy.纳米材料在推进深部肿瘤光动力疗法(PDT)及与放射疗法协同作用中的应用。
Front Bioeng Biotechnol. 2023 Oct 2;11:1250804. doi: 10.3389/fbioe.2023.1250804. eCollection 2023.
7
Enzyme-Responsive Double-Locked Photodynamic Molecular Beacon for Targeted Photodynamic Anticancer Therapy.酶响应型双锁光动力分子信标用于靶向光动力抗肿瘤治疗。
J Am Chem Soc. 2023 Apr 5;145(13):7361-7375. doi: 10.1021/jacs.2c13732. Epub 2023 Mar 24.
8
Counterion Tuning of Near-Infrared Organic Salts Dictates Phototoxicity to Inhibit Tumor Growth.反离子调控近红外有机盐的光毒性以抑制肿瘤生长。
ACS Appl Mater Interfaces. 2022 Dec 7;14(48):53511-53522. doi: 10.1021/acsami.2c16252. Epub 2022 Nov 21.
9
Singlet Oxygen, Photodynamic Therapy, and Mechanisms of Cancer Cell Death.单线态氧、光动力疗法与癌细胞死亡机制
J Oncol. 2022 Jun 25;2022:7211485. doi: 10.1155/2022/7211485. eCollection 2022.
10
Metal Nanoparticles for Photodynamic Therapy: A Potential Treatment for Breast Cancer.金属纳米粒子用于光动力疗法:治疗乳腺癌的一种潜在方法。
Molecules. 2021 Oct 29;26(21):6532. doi: 10.3390/molecules26216532.